Showing 2231-2240 of 5064 results for "".
GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muGLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reOptimizing Dermatology Office Visits With Children and Families
https://practicaldermatology.com/topics/practice-management/optimizing-dermatology-office-visits-with-children-and-families/23897/Different ages call for different approaches when seeing pediatric patients.The Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.Give Yourself Credit...The Right Way
https://practicaldermatology.com/topics/practice-management/give-yourself-credit-the-right-way/18546/Credit card processing is widely misunderstood. Processing rates vary. BA, MBM-C, CAC I-IX explains how processing fees work and what you need to know to save money and optimize revenues.Prurigo Nodularis: An Update for Clinicians, Part 1
https://practicaldermatology.com/topics/general-topics/prurigo-nodularis-an-update-for-clinicians-part-1/20507/Here's a look at the diagnosis of an “eczematous” condition with an unclear etiology.Dispelling the #1 Myth of Asset Protection
https://practicaldermatology.com/topics/practice-management/dispelling-the-1-myth-of-asset-protectionalogy/21119/Why you can lose assets in a medical malpractice lawsuitSclerotherapy - Part 1
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sclerotherapy-part-1/19505/Conversations in Acne, Part 1
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-1/19867/As treatment options for acne expand, clinicians consider the potential to combine topical therapies or pair topicals with systemics, all while adhering to guidelines for care and prescribing antibiotics responsibly. In the first episode of this three-part series, host Neal Bhatia, MD speaks with HiAudience Questions - Part 1
https://practicaldermatology.com/topics/practice-management/audience-questions-part-1/19490/